Kindstar Globalgene Technology Inc

09960

Company Profile

  • Business description

    Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.

  • Contact

    Biolake D2-1, 666 Gaoxin Road
    East Lake High Tech Zone
    Hubei Province
    Wuhan
    CHN

    https://www.kindstar.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    3,193

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,787.540.56-0.01%
DAX 4023,939.1899.01-0.41%
Dow JONES (US)42,073.4325.27-0.06%
FTSE 1008,722.353.66-0.04%
HKSE23,573.38315.071.35%
NASDAQ19,178.5377.600.41%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,902.7314.180.24%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers